vs

Side-by-side financial comparison of Bluerock Homes Trust, Inc. (BHM) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $18.9M, roughly 2.0× Bluerock Homes Trust, Inc.). On growth, Bluerock Homes Trust, Inc. posted the faster year-over-year revenue change (35.9% vs -57.1%). Over the past eight quarters, Bluerock Homes Trust, Inc.'s revenue compounded faster (30.1% CAGR vs -46.5%).

Bluerock Homes Trust, Inc. is a U.S.-headquartered real estate investment trust that acquires, owns and operates a portfolio of high-quality single-family rental residential properties. It caters to middle-market renters across high-growth suburban markets, prioritizing regions with strong demographic fundamentals and sustained rental housing demand.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

BHM vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
2.0× larger
ORGO
$37.2M
$18.9M
BHM
Growing faster (revenue YoY)
BHM
BHM
+93.0% gap
BHM
35.9%
-57.1%
ORGO
Faster 2-yr revenue CAGR
BHM
BHM
Annualised
BHM
30.1%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BHM
BHM
ORGO
ORGO
Revenue
$18.9M
$37.2M
Net Profit
$-9.5M
Gross Margin
30.8%
Operating Margin
-48.8%
-185.1%
Net Margin
-50.1%
Revenue YoY
35.9%
-57.1%
Net Profit YoY
-29.9%
EPS (diluted)
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHM
BHM
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$18.9M
$225.6M
Q3 25
$16.6M
$150.9M
Q2 25
$16.8M
$101.0M
Q1 25
$16.4M
$86.7M
Q4 24
$13.9M
$126.7M
Q3 24
$12.7M
$115.2M
Q2 24
$12.5M
$130.2M
Net Profit
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
$-9.5M
$43.7M
Q3 25
$-10.0M
$21.6M
Q2 25
$-5.8M
$-9.4M
Q1 25
$-7.3M
$-18.8M
Q4 24
$-7.3M
$7.7M
Q3 24
$3.5M
$12.3M
Q2 24
$-5.2M
$-17.0M
Gross Margin
BHM
BHM
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
BHM
BHM
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-48.8%
28.1%
Q3 25
-57.6%
13.7%
Q2 25
-30.9%
-12.5%
Q1 25
-42.6%
-30.9%
Q4 24
-52.8%
8.1%
Q3 24
27.9%
5.4%
Q2 24
-41.3%
-10.7%
Net Margin
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
-50.1%
19.4%
Q3 25
-60.0%
14.3%
Q2 25
-34.7%
-9.3%
Q1 25
-44.7%
-21.7%
Q4 24
-52.8%
6.1%
Q3 24
27.9%
10.7%
Q2 24
-41.3%
-13.1%
EPS (diluted)
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
$-0.75
$0.31
Q3 25
$-0.94
$0.11
Q2 25
$-0.66
$-0.10
Q1 25
$-0.67
$-0.17
Q4 24
$-0.65
$0.05
Q3 24
$0.24
$0.09
Q2 24
$-0.42
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHM
BHM
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$169.6M
$91.4M
Total DebtLower is stronger
$428.4M
Stockholders' EquityBook value
$128.7M
Total Assets
$1.2B
$520.0M
Debt / EquityLower = less leverage
3.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHM
BHM
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$169.6M
$93.7M
Q3 25
$2.1M
$63.7M
Q2 25
$4.2M
$73.1M
Q1 25
$3.0M
$110.0M
Q4 24
$115.2M
$135.6M
Q3 24
$155.1M
$94.3M
Q2 24
$116.0M
$89.9M
Total Debt
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
$428.4M
Q3 25
$415.9M
Q2 25
$338.6M
Q1 25
$336.5M
Q4 24
$373.8M
Q3 24
$122.5M
$62.3M
Q2 24
$119.7M
$63.8M
Stockholders' Equity
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
$128.7M
$300.1M
Q3 25
$131.7M
$255.1M
Q2 25
$135.3M
$233.2M
Q1 25
$137.1M
$242.9M
Q4 24
$139.1M
$262.9M
Q3 24
$142.9M
$278.5M
Q2 24
$142.5M
$263.5M
Total Assets
BHM
BHM
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$1.2B
$598.7M
Q3 25
$222.1M
$509.8M
Q2 25
$220.3M
$461.1M
Q1 25
$186.2M
$467.4M
Q4 24
$967.0M
$497.9M
Q3 24
$800.8M
$446.3M
Q2 24
$756.2M
$443.2M
Debt / Equity
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
3.33×
Q3 25
3.16×
Q2 25
2.50×
Q1 25
2.45×
Q4 24
2.69×
Q3 24
0.86×
0.22×
Q2 24
0.84×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHM
BHM
ORGO
ORGO
Operating Cash FlowLast quarter
$27.8M
Free Cash FlowOCF − Capex
$10.4M
FCF MarginFCF / Revenue
55.0%
Capex IntensityCapex / Revenue
91.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$25.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
$27.8M
$39.4M
Q3 25
$13.4M
$3.1M
Q2 25
$13.9M
$-32.9M
Q1 25
$951.0K
$-19.9M
Q4 24
$9.1M
$10.9M
Q3 24
$1.7M
$8.7M
Q2 24
$1.3M
$4.7M
Free Cash Flow
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
$10.4M
$34.8M
Q3 25
$8.7M
$844.0K
Q2 25
$8.8M
$-36.5M
Q1 25
$-2.9M
$-23.6M
Q4 24
$-253.0K
$7.6M
Q3 24
$-601.0K
$6.1M
Q2 24
$-654.0K
$2.9M
FCF Margin
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
55.0%
15.4%
Q3 25
52.4%
0.6%
Q2 25
52.2%
-36.1%
Q1 25
-17.6%
-27.2%
Q4 24
-1.8%
6.0%
Q3 24
-4.7%
5.3%
Q2 24
-5.2%
2.2%
Capex Intensity
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
91.8%
2.1%
Q3 25
28.5%
1.5%
Q2 25
30.3%
3.6%
Q1 25
23.4%
4.2%
Q4 24
66.9%
2.7%
Q3 24
18.0%
2.2%
Q2 24
15.3%
1.4%
Cash Conversion
BHM
BHM
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.47×
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BHM
BHM

Residential Communities Segment$11.4M61%
Scattered Single Family Homes Segment$7.5M39%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons